Antibe Therapeutics Inc(Pre-Merger) ATBPF

I asked Dan when we will go to Nasdaq...Great answer

[Marky1]

Marky1 Life is not dissimilar to the machinations in any (pre-pandemic) bar…or for that matter, any typical M&A deal... To pick someone up, you don’t look eager. You be mighty cool. And timing. You don’t rush. Most US companies who go on to Nasdaq do not trade well post-list. You and your friends seem to think an uplist to Nasdaq is a panacea…it’s fraught with difficulty. One has to be very strategic about it. The stronger we are, and the less we need it, and the more ground fertilization and watering, the better we’ll do (post-listing!! Which is everything). We’ll get better I-banks, with better buy-in on-deal and post-deal, we’ll get better terms and we’ll do better post-list. We don’t care if our stock is up or down between, say, March 10-15. We’re going for the real thing. (And it’s no longer ‘long term’ – the long term is upon us. (But relatively speaking). ( I know you look at the stock every day – but I don’t! I want us to be a billion market cap, soon. But tomorrow? Couldn’t care less. Nasdaq is very valuable for us…but on our terms. Cheers, D

0

28

[Pragmatist]

Thankyou for sharing that Marky.     He confirmed what I said in a recent post: " Getting to Nasdaq is the easy part. Sustaining SP and institutional investor interest after is more challenging."   Because of his measured approach, we can be confident that SP post-uplist will be sustainable. This is good.   For those who are interested in scratching

[clubhouse19]

Truer words have seldom been said by someone.  Uplifting without proven staying power just opens  you up to the shorting vultures in wait.  Look at how many companies who up listed prematurely got hosed . Worse of them all is is up listing to TSX where naked shorting is legal. The timing for that up listing was well timed IMO  where it looks like something like the Chinese deal